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ABSTRACT: 
OBJECTIVES: Reliable estimates of Human Norovirus (NoV) prevalence in Africa are 
limited. This review aims to assess the contribution of Human NoV to diarrheal diseases 
in Africa. METHODS: We conducted a systematic review of the PubMed and EMBASE 
databases for published articles of Human NoV in Africa between 1990 and 2013. Data 
were extracted from selected studies and analysed.                                                                                        
RESULTS: A total of 208 eligible studies were identified, of which 55 (from 19 countries) 
met the inclusion criteria. Many cases were of sporadic gastroenteritis (70.4%) in 
children (82%), 65.4% of which were seen in an outpatient setting. Over half (59.4%) of 
affected children were under 5 years of age. The pooled prevalence rate of Human NoV 
was 11% (95% CI 8-14%) and the meta-analysis indicated significant heterogeneity 
between the studies. However, the conditional negative binomial regression could not 
clearly find the factors affecting the Human NoV prevalence rates reported. A close 
relationship was found between Human NoV strains from environmental and clinical 
samples. CONCLUSION: Unreported sporadic gastroenteritis cases of Human NoV are 
common in Africa. Most of them are community-associated infections. Possible 
environmental transmission routes have been documented.  Combined environmental 
and clinical studies are required for targeted actions to control transmission of Human 
NoV in Africa. Furthermore, systematic surveillance of Human NoV is needed to 
measure the burden of NoV-induced gastroenteritis in Africa and support any 
requirements for vaccine development. 
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INTRODUCTION: 
Globally, one in ten infant deaths (before the age of 5 years) are due to diarrheal 
disease, causing almost 800,000 mortalities worldwide, most of them occurring in Sub-
Saharan Africa and South Asia (Kotloff et al. 2013; Liu et al. 2012). In Africa, 115 people 
die every hour due to diseases linked to poor sanitation, poor hygiene and 
contaminated water (UNICEF and WHO, 2012; WHO, 2011; UNICEF / WHO, 2009; 
Boshi-Pinto et al. 2008; UNICEF, 2006).  
The viruses mainly involved in diarrheal diseases include rotavirus (Greenberg and Estes, 
2009), NoV (Patel et al. 2009), astrovirus (Mitchell 2002) and adenovirus types 40 and 
41(Uhnoo et al. 1990). NoVs (previously known as “norwalk-like viruses”) were first 
discovered by electron microscopic examination of human stools (Kapikian et al. 1972) 
and are part of the Caliciviridae family along with sapovirus, lagovirus and vesivirus 
(Green et al. 2000). They are single stranded, non-enveloped, positive-sense RNA 
viruses (Jiang et al. 1993; Xi et al. 1990). There are 5 genogroups of NoV, GI-GV. Based 
on amino acid differences in the major structural protein (VP1) (Zheng et al. 2006), these 
can be further subdivided into 35 genotypes with 8 genotypes in GI, 21 in GII, 3 in GIII, 2 
in GIV and one in GV (CDC, 2011; Green 2007; Zheng et al. 2006). The strains that infect 
humans (referred to collectively as ‘’human norovirus’’) are found in GI, GII, GIV whereas 
strains infecting animals such as cows and mice fall within GII, GIII, GIV and GV (CDC, 
2011; Patel et al. 2008). NoV cannot be cultivated in vitro (Duizer et al. 2004). The use of 
molecular assays for the detection of NoV is currently commonplace in diagnostic 
laboratories (Trujillo et al. 2006).  
NoV is now the leading cause of medically attended acute gastroenteritis in USA children 
(Payne et al. 2013) and with the recent success of rotavirus vaccines, NoV will likely 
become the most common cause of childhood diarrhoea disease in many countries 
(Ramani et al. 2014; Bucardo et al. 2011; Karst 2010). In Africa, emerging Human NoV 
strains such as GII.4 2008 variant have been reported during an outbreak among South 
African hospitalised paediatric patients (Mans et al. 2010).                           
The symptoms associated with NoV infection, which manifest after an incubation period 
of between 1.2 days (95% CI 1.1-1.2 days) (Lee et al. 2013) are typically self-limiting, 
characterised by nausea, vomiting, abdominal pain and non-bloody diarrhoea (4-8 stools 
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per day). The duration of NoV illness is 12-72 hours (Patel et al. 2009), but the illness can 
be prolonged (and severe) in the very young or old, and immunocompromised persons 
(van Asten et al. 2011; Green 2007).  
NoV epidemiology is influenced by many factors including population immunity, virus 
evolution, the environment and seasonality (Ramani et al. 2014).The host genotype is a 
prominent factor in the development of NoV infection since NoV infection depends on the 
presence of specific Histo-Blood Group antigens (HBGA) receptors in the gut of 
susceptible hosts (Lindesmith et al. 2003).Transmission occurs usually from person-to-
person via the faecal-oral route or via aerosols generated by vomiting, but the importance 
of food and water in the spread of infection is also well-recognized (Daniels et al. 2000; 
Shieh et al. 2000; Kukkula et al. 1999). Several characteristics of NoVs facilitate their 
spread within the population (Hall et al. 2012; CDC, 2012; Atmar et al. 2008; Rockx et al. 
2002). These include: Extremely low infectious dose (≥ 18 viral particles), coupled with 
copious viral shedding (105-1011viral copies per gram of feces), even among 
asymptomatic infections; Environmentally stable, able to survive both freezing and 
heating, resistant to many common chemical disinfectants; Multiple ways in which NoVs 
may be transmitted; Genetically diverse group of viruses that rapidly evolve; Repeated 
infections throughout life with re-exposure, because lack of complete cross-protection 
against the diverse NoV strains and inadequate long-term immunity; Wide range of ages 
of susceptible persons as NoV can infect susceptible individuals of all ages from neonates 
to the elderly. 
Despite the excessive burden of diarrheal disease in developing countries, the majority 
of Human NoV outbreaks have so far been reported in developed countries (UNICEF, 
2012; WHO, 2011). Previous studies did generate pooled global estimates of Human 
NoV in developing and developed countries with small dataset from African countries 
where the effect of gastroenteritis probably has more severe consequences (Ahmed et 
al. 2014; Patel et al. 2009).This review provides a summation of studies that aim to 
assess the contribution of Human NoV to diarrheal diseases in Africa. In addition to the 
estimates of Human NoV in cases of gastroenteritis as previously calculated in other 
reviews (Ahmed et al. 2014; Patel et al. 2009), this review report on environmental 
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studies of Human NoV in Africa to ascertain the circulation and possible routes of 
transmission of Human NoV within the population (Iwai et al. 2003).  
 
MATERIALS AND METHODS:  
Search Strategy: 
A review of selected studies that investigated Human NoV in Africa as listed by the 
National Institutes of Health PUBMED library and EMBASE (Excerpta Medica database) 
(Appendix A) was performed using the terms ‘norovirus’ AND ‘Africa’. A second search 
was independently done for each of 54 sovereign states and 10 non-sovereign 
territories (www.nationsonline.org/org/oneworld/africa.htm) constituting the African 
continent using the following key words: Human Enteric virus, Human Calicivirus, 
Human NoV, Norwalk-virus, SRSV (small round structured virus) combined with each 
country name (Fig.1). After reviewing each article, studies were selected if they met the 
following inclusion criteria: 
 -Studies for the detection of Human NoV, Norwalk-virus, SRSV in patients with / or 
without diarrhea, in water, food and environment matrices. We included studies that 
tested for Calicivirus when NoV was differentiated from other viral agents. Diarrhea was 
defined as the passage of loose or watery stools, usually at least three times in a 24 
hour period (WHO, 2003). 
 -Studies performed in Africa between 1990 and 2013. 
 -Studies using standardized laboratory techniques for detection and / or genotyping of 
NoV including EIA, RT-PCR, qRT-PCR and Sequencing. 
Non-English articles, plus studies concerned with the detection of animal NoV were 
excluded, as were data on cases of sapovirus infection. If the authors repeated data in 
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Data extraction:  
The following information was extracted for each selected study when provided: first 
author, period and duration of study, country, clinical symptoms and settings 
(environment, outpatients and inpatients), study population, age group, diagnostic 
methods used, number of cases tested, number and percentage of positive for Human 
NoV (by genogroups and genotypes) in symptomatic and asymptomatic cases (Table 1, 
Table 2 and Appendix A).   
 
Statistical analysis:  
Data was imported to Stata DirectMT (http:www.statsdirect.co.uk /) for the calculation of 
random effects pooled prevalence rates.  This same package was used to calculate                                                                                     
heterogeneity, estimate publication bias and generate forest plots. Heterogeneity was 
assessed by Cochran’s Q test and by observing the forest plots for variation in results 
from the different studies. Publication bias was assessed by means of funnel plots and 
Harbord’s bias index. In order to determine drivers of Human NoV heterogeneity and 
genotype prevalence we conducted random effects negative binomial regression with 
STATA version 13.0. A series of single predictor models were run.   
 
RESULTS: 
The initial broad searches identified 208 studies published during 1990-2013. After 
reviewing articles on the basis of the inclusion criteria, 55 studies from 19 countries of 
Africa were eligible (Fig.1; Table 1 and Appendix A). 
Characteristics of selected studies 
Of The 55 studies included in this analysis, 42 contained only human samples, 12 only 
environmental samples and one both human and environmental samples (Table 1). A 
The majority of studies (39/55) used one form of PCR or another as the sole detection 
method, 9 used EIA and 1 EM. The remaining six studies used a combination of 
methods. Fig.1 shows the locations of the 55 studies retained from the literature search, 
revealing the regional distribution: 14 (25.4%) Northern, 4 (7.3%) Central, 14 (25.4%) 
Eastern, 10 (18.2%) Western, 11 (20%) Southern and 2 (3.6%) from the horn of Africa. 
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Thirty seven (67.3%, 37/55) of the selected studies were from 7 countries, namely: 
South Africa, Tunisia, Ghana, Tanzania, Malawi, Egypt and Kenya.     
Of the 43 studies that included human samples, 9 were from rural settings, 32 from 
urban settings and 2 from both urban and rural settings. Also 30 studies were only of 
outpatient samples, 7 from inpatient samples and the remaining 6 mixed inpatient and 
outpatient 
 
 The summary of selected studies on Human NoV in Africa (Table 1) reveals that 41 
(74.5%) of the studies were carried out in urban settings, 11 (20%) from rural areas and 
3 (5.4%) from both settings. 36 (65.4%) of studies were from non-hospitalised 
(outpatients) whereas 11 (20%) were from inpatients. Twenty two (40%) of the studies 
were carried out between 2006 and 2008. Out of 55 studies, 39 (70.9%) were from 
sporadic cases of gastroenteritis of which 32 (82.0%) were from children with diarrhea. 
Among children, the majority of cases (59.4%, 19/32) were from those under 5 years of 
age. Only 4 studies (Hassine-Zaafrane et al. 2013; Mans et al. 2010; Wolfaardt et al. 
1995; Taylor et al. 1993) from Tunisia and South Africa reported on outbreak of Human 
NoV among the selected studies. There is a great absence of NoV outbreak reports in 
Africa, perhaps due to the lack of surveillance reporting. 
 
Human NoV detection and Genotyping in Africa 
 
For the meta-analysis of prevalence rates in human samples, 7 of the 43 human studies 
were excluded for the following reasons: 
• 3 because they only included studies of outbreaks 
• 3 because they were studies of sero-prevalence and not faecal carriage (Smith, 
1999; Taylor, 1995 and Taylor, 1996) 
• 1 because the study was exclusively of healthy people and was not within the 
study period (Rodriguez-Diaz et al. 2013):   
 
Of the remaining 36 studies, 8 contained reported separately of symptomatic and 
asymptomatic participants. In these studies symptomatic and asymptomatic were 
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treated as separate study arms making 44 study arms. Figure 2 shows the forest plot of 
these 44 study arms. The random effects pooled prevalence is 11% (95% CI 8 – 14%). 
As can be seen in figure 2 with the dispersion in study prevalence there was high 
heterogeneity (Cochran Q = 1,693  (df = 43)  P < 0.0001). From supplementary file 1 
there does not appear to be any substantial publication bias. 
 
Of the 44 study arms included in the meta-analysis, 24 had sufficient information to 
enable a estimates of the proportion of positive samples associated with GI (figure 3) 
and GII (figure 4). In these studies the pooled per percentage prevalence of GI was 
18% (95%CI 12 – 24%) and GII 81% (95%CI 73 – 87%). Although again there 
substantial variation between studies. Clearly GII was the predominant genogroup in 
humans  
 
Meta-regression analysis using Poisson regression of the drivers of prevalence of 
norovirus and of the proportion due to genotype GII is shown in supplementary file 2. 
Apart from a year on year increase in the prevalence of stool positives of about 9% per 
year, none of the other possible drivers (urban/rural, outpatient/inpatient, 
symptomatic/asymptomatic, children/adults, and detection method) achieved statistical 
significance 
 
Of particular note is that 8 out of 43 human studies, reported detection of Human NoV in 
healthy controls and (participants without diarrhea) with rates ranging between 4.2% 
and 31%. The prevalence of Human NoV excretion in stools was similar in both 
symptomatic and asymptomatic participants and as already mentioned the meta-
regression analysis found no significant difference (Fig. 2; Supplementary file 2 and 3). 
If anything prevalence in asymptomatic individuals was higher than in symptomatic 
individuals.  
  
Only three studies of both age groups (children and adults) over a period of greater 
than1 year have reported Human NoV detection showing that children aged ≤ 5 years 
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were associated with an increased risk of Human NoV infection (Ayukekbong et al. 
2013; Hassine-Zaafrane et al. 2013; Kamel et al. 2009).  
Regardless of the method of Human NoV detection, the setting and the sub-regional 
climate conditions, the peak detection rate was variably reported (Supplementary file 5): 
4 studies identified the rainy season (Trainor et al. 2013; Mans et al. 2010; Papaventsis 
et al. 2007; Dove et al. 2005) as the period with the highest prevalence while 4 studies 
found peak rates in the cool dry season (Nodgren et al. 2013; Abugalia et al. 2011; 
Sdiri-Loulizi et al 2008; Armah et al. 2006). These data could not enable us to describe 
the seasonal distribution of NoV in Africa.  In addition there was no statistical difference 
in prevalence of different genogroups and genotypes with successive seasons. 
We noticed the scarcity of GIV in the selected studies.  
 
Out of twenty two studies which reported partial sequencing Human NoV, 13 (59.1%) 
were performed on capsid gene, 3 (13.6%) on polymerase gene, 5 (22.7%) on both 
ORF2 and ORF1 gene. Only one (4.5%) study was with sequence of junction region 
ORF1/ORF2. The capsid genotypes frequently reported were GII.4 (20/22, 90.9%), 
GII.6 (9/22, 40.9%), GII.3 (9/22, 40.9%) and GII.2 (9/22, 40.9%). 
A markedly genetic diversity of Human NoV has been reported in 6 (46.1%) studies with 
children ≤5 years of age (Trainor et al. 2013; Nodgren et al. 2013; Mans et al. 2010; 
Papaventis et al. 2007; Armah et al. 2006; Dove et al. 2005), showing up to 11 different 
genotypes of GII and 6 different genotypes of GI (Supplementary file 5). Two studies 
(Trainor et al. 2013; Mans et al. 2010) reported GII/GI coinfections with a median 
detection rate of 0.25% (range 0.1- 0.4). Recombinant NoV strains have been observed 
in one study from rural community of Ghana among children ≤ 5 years of age (Armah et 
al. 2006). 
 
Human Norovirus distribution in the environment 
Twelve of the selected studies (Table 2) reported on Human NoV detection in 
environmental samples, including eight water samples (from river, sewage, wastewater 
and drinking water), three shellfish samples and one soil sample. The median detection 
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rate of Human NoV in water samples was 62.2% (Range 3 - 80), with GI and GII at 
comparable frequencies. 
Studies on shellfish samples observed Human NoV contamination with a median 
detection rate of 25.5% (Range 1.6 - 35). 
In 3 selected studies, which employed molecular methods to detect NoV GIV, no 
positive environmental samples were found (Benabbes et al. 2013; Murray et al. 2013; 
Gibson et al. 2011). 
A close relationship was found in two (16.6%, 2/12) of the environmental studies 
between Human NoV strains from both environmental and clinical samples (Kamel et al. 
2010; Sdiri-Loulizi et al. 2010) meaning a correlation between the genogroups and 
genotypes seen in the environmental and clinical samples during the same period 
study. Phylogenetic analyses revealed that environmental Human NoV strains were 
similar to those found in children suffering from gastroenteritis during the same period 
study. 
Out of seven studies which reported on the seasonality, six (85.7%) showed no pattern 




This review provides a summary of Human NoV detection studies in Africa, two 
decades after the introduction of molecular assays to detect NoVs. Only 55 studies 
fulfilled the inclusion criteria of this review highlighting the need for further work to 
assess the burden of Human NoV gastroenteritis in Africa. There are many areas of 
Africa where very little is known regarding the contribution of Human NoV to diarrhoeal 
disease, reflected in the fact that the majority of studies (37/55) came from only 7 
countries (South Africa, Tunisia, Ghana, Tanzania, Malawi, Egypt and Kenya (Table 1).  
The data imply that Nov could be a common cause of moderate gastroenteritis among 
children under 5 years of age in Africa. The review showed that 70.9% (39/55) of 
selected studies were from sporadic gastroenteritis of which 48.7% (19/39) were among 
children with ≤ 5 years of age. This is consistent with the global increase of Human NoV 
in sporadic gastroenteritis in children under 5 years of age worldwide (Hoa Tran et al. 
  11 
 
2013; Patel et al. 2008). However, the observation that the prevalence of Human NoV 
excretion in stools is similar in both symptomatic and asymptomatic participants raises 
questions about its pathogenic role and the immune status of the hosts. Indeed, in three 
of the four studies that compared samples for symptomatic and asymptomatic 
participants, the reported rates were lower in symptomatic patients than in 
asymptomatic controls (Huynen et al. 2013, Mattison et al. 2010, Trainor et al. 2013). 
The results of these studies indicate that the relationship between Human NoV infection 
and clinical disease is complex in Africa and requires further investigation. 
Nevertheless, the possibility of post-symptomatic shedding cannot be excluded 
considering the fact that the healthy children in the indicated reports were participants 
with no history of diarrhoea 2 weeks before sample collection (and in many cases, 
highly sensitive methods of detection were used). Previous studies have shown that 
Human NoV may be shed in faeces for over 3 weeks after symptoms (Milbrath et al. 
2013; Atmar et al. 2008; Siebenga et al. 2008), although the infectivity of the virus after 
this time is not clear. Recently Moyo et al. (2014) who investigated in Tanzania on 705 
hospitalized children with diarrhoea and 561 children without history of diarrhoea for one 
month prior to the study, found that prevalence of NoV was significantly higher in cases 
(18.3 %) than in controls (9.3 %).      
Most of the studies (80%, 44/55) were carried out in urban settings, likely due to the 
lack of laboratory capacity for Human NoV detection in rural settings.  The analyses 
revealed that 65.4% (36/55) of studies were of outpatients, indicating that Human NoV 
is a common viral agent of community acquired diarrhea in Africa.  
In line with the predictions of some authors, the summary of studies confirms that GII is 
the predominant genogroup and GII.4 genotype followed by GII.3, GII.2 and GII.6 as the 
predominant genotypes circulating in communities worldwide (Hoa Tran et al. 2013; 
Siebenga et al. 2009; Patel et al. 2008). The GI strains (9.1%, 5/55) were mostly 
detected from environmental samples (El-Senousy et al. 2013; Mans et al. 2013; Kamel 
et al. 2010; Polo et al. 2010; Sdiri-Loulizi et al. 2010), which is in keeping with previous 
studies. It is possible that GI strains are more environmentally stable relative to GII 
strains (Mathews et al. 2012; Seitz et al. 2011; Atmar, 2010; Charles et al. 2009; Lysen 
et al. 2009). 
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Human NoV detection was found more frequently in children than in adults in 3 studies 
of both age groups over a period of greater than1 year. Unfortunately the small numbers 
of these reports in the present review did not allow us to draw any conclusions about 
transmission patterns in different age groups. 
The pooled prevalence rate of Human NoV was 11 % (95% CI 8-14%) (Fig. 2). Sporadic 
gastroenteritis due to Human NoV in childhood, in the developing world, remains poorly 
described. There is no reporting system of NoV infection in the primary healthcare 
system, meaning that sporadic cases of Human NoV are likely to be vastly 
underreported and the prevalence of the infections grossly underestimated. 
Nevertheless, the combined prevalence of Human NoV among children under 5 years 
of age with diarrhoea, found in this review, is comparable to a previous global 
systematic review in which the pooled Human NoV detection rate was 12% in children 
under 5 (95% confidence interval 10%-15%) (Patel et al. 2008). The high frequency of 
Human NoV in sporadic infantile cases is a potential health risk as these children may 
act as reservoir for emerging epidemic Human NoV strains (Medici et al. 2006).   
The limited number of studies that reported on the distribution of Human NoV in 
gastroenteritis cases throughout the year does not allow us to describe the seasonal 
distribution of Human NoV in Africa. Knowledge of the seasonality and influence of 
weather conditions on the transmission of the viruses in the community provides 
information needed to predict when a peak period is likely to occur, to instigate public 
health interventions. Therefore, more studies of at least 12 months duration are needed 
to determine the seasonal distribution of Human NoV in all regions of Africa. The 
majority (85.7%) of the studies on environmental samples (Table 2) showed no 
seasonal peaks or troughs of Human NoV throughout the year. Similar observations 
have been reported in previous studies (Lysen et al. 2009; Maunula et al. 2005). Human 
NoV has been shown to persist for long periods of time, which may go some way to 
explain their detection all year long (Lopman et al. 2012; Seitz et al. 2011; Le Guyader 
et al. 2000). Existing evidence suggests that Human NoV is environmentally stable and 
resistant to disinfection, and that environmental contamination with Human NoV is 
common both within and outside outbreak settings (Lopman et al. 2012; Seitz et al. 
2011; CDC, 2008).  Co-circulation of Human NoV in the environment and the population 
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has been reported in 16.6% of environmental surveys of this review. Phylogenetic 
analyses have revealed a close relationship between environmental Human NoV clinical 
cases within the same period of time (Kamel et al. 2010; Sdiri-Loulizi et al. 2010). This 
finding indicates that there are potential health risks associated with transmission of 
Human NoV via environmental routes. 
A remarkably high genetic diversity of Human NoV in children under 5 years of age 
have been reported in this review, suggesting that NoV is likely to be common in Africa.  
However diversity of Human NoV has been previously reported worldwide (Zheng et al. 
2011; Kremer et al. 2011; Ferreira et al. 2010; Reuter et al. 2005; Hanoman et al. 2004). 
Although the studies included in this review provide an indication of the circulating 
Human NoV strains across the African continent, they are not fully representative of all 
countries. Moreover, comparing the occurrence of Human NoV in Africa is difficult due 
to differing study/site conditions and the range of techniques used for sampling and 
detection. The lack of data may be attributed to the fact that Human NoV detection 
methods are costly and require specialised laboratories and expertise. Furthermore, 
due to the limited number of selected studies, we are unable to ascertain whether 
Human NoV diversity in children with gastroenteritis is related to the genetic ability of 
Human NoV itself to evolve rapidly (Hall et al. 2012; CDC, 2012; Bull et al. 2006) or to 
regional prevalence. 
In conclusion, this review has found a high prevalence of Human NoV among children in 
Africa. The potential for environmental transmission routes of Human NoV has been 
highlighted. Joint environmental and clinical surveys, during the same period, are 
warranted (Iwai et al. 2009) and these can also be used to gage the effectiveness of 
control measures that aim to reduce environmental transmission. The relationship 
between Human NoV infection and disease in Africa is complex. This review highlights 
the need for systematic surveillance of gastroenteritis caused by Human NoV in children 
in Africa, as they may provide an efficient way to monitor the emergence of variant 
strains and to assist with the development of Human NoV vaccines.   
    
 
 







We would like to express our gratitude to Dr Safi Troare (University of Venda), Dr Valery 
Tshilombo (University of Stellenbosch), the library staff members of the University of 
Venda and the Norfolk and Norwich University Hospital (NNUH) who provided 
assistance for this review. This study was funded by the SNOWS consortium (Wellcome 
Trust) as part of the African initiative in building capacity. 
 
AUTHOR DISCLOSURE STATEMENT 
 
No competing financial interests exist. 
 
Appendix A. Supplementary data 
 
The following are the supplementary data to this review: 
1. Supplementary file 1: Flow chart displaying the study profile. 
2. Supplementary file 2: Funnel of standard errors for included studies. (A) 
Prevalence studies of Human NoV. 
3. Supplementary file 3: Meta-regression analysis of factors affecting proportion 
positive and genotypes. 
4. Supplementary file 4: Distribution of Human NoV infections in sporadic 
gastroenteritis from different countries of Africa, January 1990-December 2013. 
5. Supplementary file 5: Distribution of Human NoV genogroups (genotypes) among  
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Figure 1: Distribution of selected studies for Human NoV in Africa. 55 selected studies where from 19 
countries including: South Africa, Botswana, Malawi, Madagascar, Rwanda, Tanzania, Kenya, Ethiopia, 
Djibouti, Chad, Democratic Republic of Congo, Cameroon, Egypt, Morocco, Tunisia, Libya, Ghana, Nigeria 
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